

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.10793819 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.10793819 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.10793819 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.10793819 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.10793819 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.10793819 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 6.16449655 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.02576547 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.90334352 |
| 10 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.15922589 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.98905298 |
| 12 | DNA deamination (GO:0045006) | 4.93138536 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.77813123 |
| 14 | response to peptidoglycan (GO:0032494) | 4.74515885 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.73648269 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.71537122 |
| 17 | response to host immune response (GO:0052572) | 4.71537122 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.68732988 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 4.58483769 |
| 20 | respiratory burst (GO:0045730) | 4.51108275 |
| 21 | microglial cell activation (GO:0001774) | 4.47356997 |
| 22 | piRNA metabolic process (GO:0034587) | 4.43350730 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 4.35078005 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 4.31783005 |
| 25 | behavioral response to nicotine (GO:0035095) | 4.27550626 |
| 26 | cellular extravasation (GO:0045123) | 4.23433696 |
| 27 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.21969022 |
| 28 | response to host (GO:0075136) | 4.21969022 |
| 29 | response to host defenses (GO:0052200) | 4.21969022 |
| 30 | positive regulation of mast cell activation (GO:0033005) | 4.10173535 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.08575396 |
| 32 | regulation of cholesterol storage (GO:0010885) | 4.06500892 |
| 33 | fucose catabolic process (GO:0019317) | 4.05755187 |
| 34 | L-fucose metabolic process (GO:0042354) | 4.05755187 |
| 35 | L-fucose catabolic process (GO:0042355) | 4.05755187 |
| 36 | neutrophil activation (GO:0042119) | 4.04642324 |
| 37 | pinocytosis (GO:0006907) | 3.97779859 |
| 38 | macrophage activation (GO:0042116) | 3.96045157 |
| 39 | granulocyte activation (GO:0036230) | 3.90920564 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.86418530 |
| 41 | respiratory chain complex IV assembly (GO:0008535) | 3.86412698 |
| 42 | regulation of mononuclear cell migration (GO:0071675) | 3.85304626 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.82156425 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.77430144 |
| 45 | regulation of mast cell activation (GO:0033003) | 3.74320650 |
| 46 | negative regulation of mast cell activation (GO:0033004) | 3.73649516 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.72631620 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.69801727 |
| 49 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.69183651 |
| 50 | platelet dense granule organization (GO:0060155) | 3.65505336 |
| 51 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.61448794 |
| 52 | cytochrome complex assembly (GO:0017004) | 3.61294410 |
| 53 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.58802844 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.57932582 |
| 55 | DNA methylation involved in gamete generation (GO:0043046) | 3.57270675 |
| 56 | response to pheromone (GO:0019236) | 3.56930224 |
| 57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.55781336 |
| 58 | positive regulation of mast cell degranulation (GO:0043306) | 3.55781336 |
| 59 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.47645302 |
| 60 | positive regulation of macrophage cytokine production (GO:0060907) | 3.47482238 |
| 61 | axoneme assembly (GO:0035082) | 3.46264754 |
| 62 | superoxide anion generation (GO:0042554) | 3.44230879 |
| 63 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.43818739 |
| 64 | protein complex biogenesis (GO:0070271) | 3.43662211 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.37751941 |
| 66 | neutrophil mediated immunity (GO:0002446) | 3.35010429 |
| 67 | mannosylation (GO:0097502) | 3.34997605 |
| 68 | protein-cofactor linkage (GO:0018065) | 3.34934001 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.34834567 |
| 70 | B cell mediated immunity (GO:0019724) | 3.32785429 |
| 71 | positive regulation of interferon-beta production (GO:0032728) | 3.32429563 |
| 72 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.31483131 |
| 73 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.31073096 |
| 74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.28080299 |
| 75 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.26819007 |
| 76 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.24328251 |
| 77 | protein polyglutamylation (GO:0018095) | 3.24219556 |
| 78 | negative regulation of telomere maintenance (GO:0032205) | 3.20103278 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15914479 |
| 80 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.15699629 |
| 81 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.15699629 |
| 82 | NADH dehydrogenase complex assembly (GO:0010257) | 3.15699629 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15165213 |
| 84 | positive regulation of leukocyte degranulation (GO:0043302) | 3.13957726 |
| 85 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.13537497 |
| 86 | I-kappaB phosphorylation (GO:0007252) | 3.13000591 |
| 87 | indolalkylamine metabolic process (GO:0006586) | 3.11534647 |
| 88 | detection of light stimulus involved in visual perception (GO:0050908) | 3.10779397 |
| 89 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.10779397 |
| 90 | lipoxygenase pathway (GO:0019372) | 3.10400903 |
| 91 | adaptation of signaling pathway (GO:0023058) | 3.09653689 |
| 92 | response to muramyl dipeptide (GO:0032495) | 3.09334418 |
| 93 | neutrophil chemotaxis (GO:0030593) | 3.07200147 |
| 94 | kidney morphogenesis (GO:0060993) | 3.05083987 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 3.04574131 |
| 96 | DNA double-strand break processing (GO:0000729) | 3.03546886 |
| 97 | lymphocyte chemotaxis (GO:0048247) | 3.03439633 |
| 98 | regulation of glucokinase activity (GO:0033131) | 3.03311538 |
| 99 | regulation of hexokinase activity (GO:1903299) | 3.03311538 |
| 100 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.02584767 |
| 101 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.01780179 |
| 102 | leukocyte mediated cytotoxicity (GO:0001909) | 2.99537257 |
| 103 | neural tube formation (GO:0001841) | 2.99521258 |
| 104 | cytidine metabolic process (GO:0046087) | 2.98835159 |
| 105 | cytidine catabolic process (GO:0006216) | 2.98835159 |
| 106 | cytidine deamination (GO:0009972) | 2.98835159 |
| 107 | reactive oxygen species biosynthetic process (GO:1903409) | 2.98598078 |
| 108 | neutrophil migration (GO:1990266) | 2.98194252 |
| 109 | leukotriene metabolic process (GO:0006691) | 2.96633369 |
| 110 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.96402422 |
| 111 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.95930790 |
| 112 | low-density lipoprotein particle clearance (GO:0034383) | 2.94302247 |
| 113 | phagosome maturation (GO:0090382) | 2.94065077 |
| 114 | response to thyroid hormone (GO:0097066) | 2.92728611 |
| 115 | positive regulation of lipid storage (GO:0010884) | 2.91781836 |
| 116 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.91655333 |
| 117 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90692852 |
| 118 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89483322 |
| 119 | negative regulation of cell killing (GO:0031342) | 2.89483322 |
| 120 | T-helper 1 type immune response (GO:0042088) | 2.88184679 |
| 121 | ketone body metabolic process (GO:1902224) | 2.88011344 |
| 122 | hyaluronan catabolic process (GO:0030214) | 2.87714866 |
| 123 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.86599874 |
| 124 | epithelial cilium movement (GO:0003351) | 2.86547103 |
| 125 | myeloid leukocyte activation (GO:0002274) | 2.86186627 |
| 126 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.82831572 |
| 127 | regulation of meiosis I (GO:0060631) | 2.81871693 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81762833 |
| 129 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.81569701 |
| 130 | photoreceptor cell maintenance (GO:0045494) | 2.81244743 |
| 131 | regulation of macrophage cytokine production (GO:0010935) | 2.80786792 |
| 132 | base-excision repair, AP site formation (GO:0006285) | 2.79639671 |
| 133 | regulation of monocyte chemotaxis (GO:0090025) | 2.79556935 |
| 134 | granulocyte chemotaxis (GO:0071621) | 2.78929523 |
| 135 | negative regulation of interleukin-12 production (GO:0032695) | 2.78867250 |
| 136 | apoptotic cell clearance (GO:0043277) | 2.78103913 |
| 137 | positive regulation of defense response to virus by host (GO:0002230) | 2.77534163 |
| 138 | male meiosis (GO:0007140) | 2.77345811 |
| 139 | tryptophan catabolic process (GO:0006569) | 2.76905757 |
| 140 | indole-containing compound catabolic process (GO:0042436) | 2.76905757 |
| 141 | indolalkylamine catabolic process (GO:0046218) | 2.76905757 |
| 142 | eosinophil chemotaxis (GO:0048245) | 2.76808580 |
| 143 | negative regulation of interleukin-6 production (GO:0032715) | 2.76255696 |
| 144 | positive regulation of T cell migration (GO:2000406) | 2.75716651 |
| 145 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75441577 |
| 146 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.74088332 |
| 147 | negative regulation of granulocyte differentiation (GO:0030853) | 2.73738980 |
| 148 | leukocyte aggregation (GO:0070486) | 2.73680354 |
| 149 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72776102 |
| 150 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.72632966 |
| 151 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.72494700 |
| 152 | regulation of cilium movement (GO:0003352) | 2.72420488 |
| 153 | kynurenine metabolic process (GO:0070189) | 2.71709777 |
| 154 | iron-sulfur cluster assembly (GO:0016226) | 2.71265233 |
| 155 | metallo-sulfur cluster assembly (GO:0031163) | 2.71265233 |
| 156 | cornea development in camera-type eye (GO:0061303) | 2.71195396 |
| 157 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.70675425 |
| 158 | recombinational repair (GO:0000725) | 2.70164362 |
| 159 | double-strand break repair via homologous recombination (GO:0000724) | 2.69777195 |
| 160 | gamma-aminobutyric acid transport (GO:0015812) | 2.69509226 |
| 161 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.69237570 |
| 162 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.67993264 |
| 163 | retinal cone cell development (GO:0046549) | 2.67962565 |
| 164 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.67374453 |
| 165 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.67374453 |
| 166 | pseudouridine synthesis (GO:0001522) | 2.65729319 |
| 167 | replication fork processing (GO:0031297) | 2.63524379 |
| 168 | auditory receptor cell stereocilium organization (GO:0060088) | 2.61856269 |
| 169 | S-adenosylmethionine metabolic process (GO:0046500) | 2.61733073 |
| 170 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.61590068 |
| 171 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.58525141 |
| 172 | positive regulation of fatty acid transport (GO:2000193) | 2.55389969 |
| 173 | DNA demethylation (GO:0080111) | 2.54100324 |
| 174 | inositol phosphate catabolic process (GO:0071545) | 2.53991483 |
| 175 | positive regulation of prostaglandin secretion (GO:0032308) | 2.53693491 |
| 176 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.52865967 |
| 177 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.50322916 |
| 178 | male meiosis I (GO:0007141) | 2.48603174 |
| 179 | nonmotile primary cilium assembly (GO:0035058) | 2.48061137 |
| 180 | glycerophospholipid catabolic process (GO:0046475) | 2.47793939 |
| 181 | cilium morphogenesis (GO:0060271) | 2.47292824 |
| 182 | centriole replication (GO:0007099) | 2.47171340 |
| 183 | GPI anchor metabolic process (GO:0006505) | 2.47053290 |
| 184 | reflex (GO:0060004) | 2.46272470 |
| 185 | rhodopsin mediated signaling pathway (GO:0016056) | 2.46201821 |
| 186 | tryptophan metabolic process (GO:0006568) | 2.45850493 |
| 187 | multicellular organism reproduction (GO:0032504) | 2.45490157 |
| 188 | photoreceptor cell development (GO:0042461) | 2.43509447 |
| 189 | cilium movement (GO:0003341) | 2.43450459 |
| 190 | anterograde synaptic vesicle transport (GO:0048490) | 2.42219284 |
| 191 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.40989055 |
| 192 | cell wall macromolecule catabolic process (GO:0016998) | 2.40721732 |
| 193 | ubiquinone biosynthetic process (GO:0006744) | 2.39601247 |
| 194 | tachykinin receptor signaling pathway (GO:0007217) | 2.38819704 |
| 195 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.38293140 |
| 196 | reciprocal DNA recombination (GO:0035825) | 2.38207920 |
| 197 | reciprocal meiotic recombination (GO:0007131) | 2.38207920 |
| 198 | rRNA catabolic process (GO:0016075) | 2.37398178 |
| 199 | cilium organization (GO:0044782) | 2.35820052 |
| 200 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.33771871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.03753134 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.93906828 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.42148601 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.12405598 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.91969072 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.44219614 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.09416227 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.02181405 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 3.61039608 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.52074693 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.22777207 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.98883883 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.90098924 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76263287 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74482886 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.70328615 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.68448968 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.64368431 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54859034 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51277830 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.50622658 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.46644264 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36263521 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.34323832 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.33974619 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30252082 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.30244277 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29824298 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21320957 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18765573 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.15457458 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13364342 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.09969262 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.09418186 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 2.08133406 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.07358035 |
| 37 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.05302517 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 2.04881160 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 2.01161335 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.95671750 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.93089781 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92934355 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91880974 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90933833 |
| 45 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.89308185 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.87906237 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87762922 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.87626160 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.84588690 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83496501 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76266122 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.75666368 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74609158 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73581861 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72859239 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.71967773 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70762443 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70601953 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.69485313 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65620378 |
| 61 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.64735028 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.63860332 |
| 63 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.60833342 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.60526747 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.57606943 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.57074008 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.56795976 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.55822496 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.55822496 |
| 70 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55551374 |
| 71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.55420366 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54493303 |
| 73 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.53696434 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.51823004 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48828195 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48719490 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46710304 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.44883931 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43039491 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.41755421 |
| 81 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.41755421 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.41593710 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41346702 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41095778 |
| 85 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.40235587 |
| 86 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38576737 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36527536 |
| 88 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36000695 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.35473530 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35144196 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34313325 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.32720809 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.32538103 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.31860949 |
| 95 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31708050 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31582210 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30935351 |
| 98 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29628388 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29127030 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28746248 |
| 101 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.28633320 |
| 102 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.28633320 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28460024 |
| 104 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27885800 |
| 105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27810195 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27682894 |
| 107 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27643026 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27584419 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27249007 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27249007 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26941949 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26659053 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26643860 |
| 114 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25466690 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25161048 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25023670 |
| 117 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25001379 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24254039 |
| 119 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.23778238 |
| 120 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.23426289 |
| 121 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22182565 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22112544 |
| 123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20828952 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19202463 |
| 125 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18562237 |
| 126 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.18406376 |
| 127 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18311301 |
| 128 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17827965 |
| 129 | AR_20517297_ChIP-Seq_VCAP_Human | 1.17709053 |
| 130 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16340419 |
| 131 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15163012 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14834303 |
| 133 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.14646691 |
| 134 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13781242 |
| 135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13702960 |
| 136 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11585885 |
| 137 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11426671 |
| 138 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11417044 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11180451 |
| 140 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11017918 |
| 141 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10791064 |
| 142 | MYB_26560356_Chip-Seq_TH1_Human | 1.10066219 |
| 143 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09529718 |
| 144 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08778823 |
| 145 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08693374 |
| 146 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08257555 |
| 147 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.08015202 |
| 148 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07259883 |
| 149 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05402762 |
| 150 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05398487 |
| 151 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04963346 |
| 152 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.04322894 |
| 153 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04262856 |
| 154 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.04250776 |
| 155 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04025374 |
| 156 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03155808 |
| 157 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02800576 |
| 158 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01413811 |
| 159 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00248067 |
| 160 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99799040 |
| 161 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99698686 |
| 162 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99685297 |
| 163 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99538815 |
| 164 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99024268 |
| 165 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98095831 |
| 166 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97461401 |
| 167 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96266583 |
| 168 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94241882 |
| 169 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94207945 |
| 170 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93850673 |
| 171 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93850673 |
| 172 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93646751 |
| 173 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90551299 |
| 174 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88465503 |
| 175 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85180280 |
| 176 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82361321 |
| 177 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82250652 |
| 178 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81939603 |
| 179 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81225496 |
| 180 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80580220 |
| 181 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.77900859 |
| 182 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77715967 |
| 183 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77432717 |
| 184 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77154319 |
| 185 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76917787 |
| 186 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75367303 |
| 187 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73343397 |
| 188 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72016564 |
| 189 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.71561079 |
| 190 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69455922 |
| 191 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69373238 |
| 192 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69270227 |
| 193 | CJUN_26792858_Chip-Seq_BT549_Human | 0.69050071 |
| 194 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68802771 |
| 195 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68076674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.83566836 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.22218701 |
| 3 | MP0003436_decreased_susceptibility_to | 3.98763857 |
| 4 | MP0008877_abnormal_DNA_methylation | 3.71222177 |
| 5 | MP0003303_peritoneal_inflammation | 3.39785663 |
| 6 | MP0002419_abnormal_innate_immunity | 3.38703146 |
| 7 | MP0003787_abnormal_imprinting | 3.26218999 |
| 8 | MP0002102_abnormal_ear_morphology | 3.21921753 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.97461624 |
| 10 | MP0006082_CNS_inflammation | 2.84137324 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.82189143 |
| 12 | MP0003195_calcinosis | 2.70155800 |
| 13 | MP0009840_abnormal_foam_cell | 2.68891103 |
| 14 | MP0009785_altered_susceptibility_to | 2.68483281 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.68173534 |
| 16 | MP0005025_abnormal_response_to | 2.64613872 |
| 17 | MP0004510_myositis | 2.52322614 |
| 18 | MP0003724_increased_susceptibility_to | 2.48546206 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.47887789 |
| 20 | MP0005387_immune_system_phenotype | 2.47843074 |
| 21 | MP0001790_abnormal_immune_system | 2.47843074 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.45417697 |
| 23 | MP0006072_abnormal_retinal_apoptosis | 2.31308778 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.30944546 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.30936653 |
| 26 | MP0003690_abnormal_glial_cell | 2.27122750 |
| 27 | MP0001986_abnormal_taste_sensitivity | 2.26223198 |
| 28 | MP0001533_abnormal_skeleton_physiology | 2.25587720 |
| 29 | MP0000372_irregular_coat_pigmentation | 2.24933353 |
| 30 | MP0001800_abnormal_humoral_immune | 2.23210549 |
| 31 | MP0000685_abnormal_immune_system | 2.22463667 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 2.21269341 |
| 33 | MP0002653_abnormal_ependyma_morphology | 2.13540398 |
| 34 | MP0005646_abnormal_pituitary_gland | 2.11108018 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 2.09945197 |
| 36 | MP0000604_amyloidosis | 2.07723835 |
| 37 | MP0002723_abnormal_immune_serum | 2.07131569 |
| 38 | MP0005464_abnormal_platelet_physiology | 2.01972954 |
| 39 | MP0003075_altered_response_to | 2.00057122 |
| 40 | MP0000343_altered_response_to | 1.99561920 |
| 41 | MP0005671_abnormal_response_to | 1.96060568 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.94424354 |
| 43 | MP0001819_abnormal_immune_cell | 1.94399788 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.94043451 |
| 45 | MP0002405_respiratory_system_inflammati | 1.93006078 |
| 46 | MP0005253_abnormal_eye_physiology | 1.90617438 |
| 47 | MP0002736_abnormal_nociception_after | 1.90575939 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.83301077 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.78701984 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.78680179 |
| 51 | MP0006292_abnormal_olfactory_placode | 1.78622079 |
| 52 | MP0005310_abnormal_salivary_gland | 1.71481054 |
| 53 | MP0003448_altered_tumor_morphology | 1.65969813 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.64353066 |
| 55 | MP0002163_abnormal_gland_morphology | 1.63533759 |
| 56 | MP0003646_muscle_fatigue | 1.63208393 |
| 57 | MP0004142_abnormal_muscle_tone | 1.62563792 |
| 58 | MP0009764_decreased_sensitivity_to | 1.62079417 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.62062578 |
| 60 | MP0008469_abnormal_protein_level | 1.62018181 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60638054 |
| 62 | MP0009745_abnormal_behavioral_response | 1.57137484 |
| 63 | MP0002938_white_spotting | 1.57109665 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.55718771 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.54235122 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.54148553 |
| 67 | MP0008872_abnormal_physiological_respon | 1.53910124 |
| 68 | MP0002928_abnormal_bile_duct | 1.53797345 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 1.50822883 |
| 70 | MP0003136_yellow_coat_color | 1.49555323 |
| 71 | MP0005166_decreased_susceptibility_to | 1.48818062 |
| 72 | MP0001853_heart_inflammation | 1.48714299 |
| 73 | MP0009046_muscle_twitch | 1.46470481 |
| 74 | MP0002272_abnormal_nervous_system | 1.44430621 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.42280293 |
| 76 | MP0001486_abnormal_startle_reflex | 1.41594764 |
| 77 | MP0004947_skin_inflammation | 1.39919668 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.39312096 |
| 79 | MP0003121_genomic_imprinting | 1.38423348 |
| 80 | MP0001485_abnormal_pinna_reflex | 1.37820744 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.35986592 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.35376421 |
| 83 | MP0010155_abnormal_intestine_physiology | 1.34013087 |
| 84 | MP0000716_abnormal_immune_system | 1.33940031 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 1.33303403 |
| 86 | MP0006276_abnormal_autonomic_nervous | 1.32654945 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 1.32517505 |
| 88 | MP0003828_pulmonary_edema | 1.31754603 |
| 89 | MP0000427_abnormal_hair_cycle | 1.31073274 |
| 90 | MP0001984_abnormal_olfaction | 1.29424377 |
| 91 | MP0004147_increased_porphyrin_level | 1.28686004 |
| 92 | MP0009278_abnormal_bone_marrow | 1.27839713 |
| 93 | MP0002095_abnormal_skin_pigmentation | 1.25148807 |
| 94 | MP0000689_abnormal_spleen_morphology | 1.24493236 |
| 95 | MP0008058_abnormal_DNA_repair | 1.23768055 |
| 96 | MP0003011_delayed_dark_adaptation | 1.22995808 |
| 97 | MP0003880_abnormal_central_pattern | 1.18589990 |
| 98 | MP0003122_maternal_imprinting | 1.18455179 |
| 99 | MP0004885_abnormal_endolymph | 1.17864226 |
| 100 | MP0005410_abnormal_fertilization | 1.15807448 |
| 101 | MP0004742_abnormal_vestibular_system | 1.14990244 |
| 102 | MP0004043_abnormal_pH_regulation | 1.14898337 |
| 103 | MP0001851_eye_inflammation | 1.12728440 |
| 104 | MP0005389_reproductive_system_phenotype | 1.12480148 |
| 105 | MP0002398_abnormal_bone_marrow | 1.11702690 |
| 106 | MP0000858_altered_metastatic_potential | 1.11116136 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 1.09933129 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 1.09085314 |
| 109 | MP0008995_early_reproductive_senescence | 1.08946665 |
| 110 | MP0004133_heterotaxia | 1.08746909 |
| 111 | MP0000015_abnormal_ear_pigmentation | 1.07309841 |
| 112 | MP0002733_abnormal_thermal_nociception | 1.06025783 |
| 113 | MP0002429_abnormal_blood_cell | 1.05917626 |
| 114 | MP0005164_abnormal_response_to | 1.05726597 |
| 115 | MP0005390_skeleton_phenotype | 1.04198474 |
| 116 | MP0002572_abnormal_emotion/affect_behav | 1.04119863 |
| 117 | MP0001764_abnormal_homeostasis | 1.03933550 |
| 118 | MP0008789_abnormal_olfactory_epithelium | 1.03908235 |
| 119 | MP0002735_abnormal_chemical_nociception | 1.01645806 |
| 120 | MP0005397_hematopoietic_system_phenotyp | 1.01533604 |
| 121 | MP0001545_abnormal_hematopoietic_system | 1.01533604 |
| 122 | MP0002933_joint_inflammation | 1.01273858 |
| 123 | MP0003566_abnormal_cell_adhesion | 1.01060848 |
| 124 | MP0005195_abnormal_posterior_eye | 1.00995710 |
| 125 | MP0009763_increased_sensitivity_to | 1.00827689 |
| 126 | MP0010307_abnormal_tumor_latency | 1.00686325 |
| 127 | MP0001970_abnormal_pain_threshold | 0.99250233 |
| 128 | MP0002638_abnormal_pupillary_reflex | 0.98965858 |
| 129 | MP0002722_abnormal_immune_system | 0.98541077 |
| 130 | MP0005377_hearing/vestibular/ear_phenot | 0.98280795 |
| 131 | MP0003878_abnormal_ear_physiology | 0.98280795 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.98134537 |
| 133 | MP0004883_abnormal_blood_vessel | 0.97859378 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.97094064 |
| 135 | MP0003786_premature_aging | 0.96667421 |
| 136 | MP0003718_maternal_effect | 0.96076000 |
| 137 | MP0004145_abnormal_muscle_electrophysio | 0.95820616 |
| 138 | MP0005076_abnormal_cell_differentiation | 0.94870056 |
| 139 | MP0004130_abnormal_muscle_cell | 0.93954739 |
| 140 | MP0002160_abnormal_reproductive_system | 0.93603531 |
| 141 | MP0000249_abnormal_blood_vessel | 0.93442230 |
| 142 | MP0001529_abnormal_vocalization | 0.93172372 |
| 143 | MP0002166_altered_tumor_susceptibility | 0.92323859 |
| 144 | MP0003252_abnormal_bile_duct | 0.91858629 |
| 145 | MP0006036_abnormal_mitochondrial_physio | 0.91121574 |
| 146 | MP0001905_abnormal_dopamine_level | 0.90966513 |
| 147 | MP0002064_seizures | 0.90651163 |
| 148 | MP0010329_abnormal_lipoprotein_level | 0.90173299 |
| 149 | MP0001929_abnormal_gametogenesis | 0.88367347 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.87996647 |
| 151 | MP0001919_abnormal_reproductive_system | 0.86177354 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.84994111 |
| 153 | MP0002254_reproductive_system_inflammat | 0.84696037 |
| 154 | MP0002229_neurodegeneration | 0.84433468 |
| 155 | MP0002067_abnormal_sensory_capabilities | 0.84083785 |
| 156 | MP0003795_abnormal_bone_structure | 0.83576243 |
| 157 | MP0000920_abnormal_myelination | 0.83563980 |
| 158 | MP0003806_abnormal_nucleotide_metabolis | 0.83543530 |
| 159 | MP0003698_abnormal_male_reproductive | 0.83427334 |
| 160 | MP0000516_abnormal_urinary_system | 0.83034451 |
| 161 | MP0005367_renal/urinary_system_phenotyp | 0.83034451 |
| 162 | MP0005386_behavior/neurological_phenoty | 0.81048190 |
| 163 | MP0004924_abnormal_behavior | 0.81048190 |
| 164 | MP0008260_abnormal_autophagy | 0.80515024 |
| 165 | MP0006035_abnormal_mitochondrial_morpho | 0.80309871 |
| 166 | MP0001324_abnormal_eye_pigmentation | 0.79680534 |
| 167 | MP0002751_abnormal_autonomic_nervous | 0.78445249 |
| 168 | MP0002210_abnormal_sex_determination | 0.78440164 |
| 169 | MP0008438_abnormal_cutaneous_collagen | 0.77460146 |
| 170 | MP0000609_abnormal_liver_physiology | 0.74660474 |
| 171 | MP0002752_abnormal_somatic_nervous | 0.74547659 |
| 172 | MP0005083_abnormal_biliary_tract | 0.73678883 |
| 173 | MP0005085_abnormal_gallbladder_physiolo | 0.73169714 |
| 174 | MP0002006_tumorigenesis | 0.72313429 |
| 175 | MP0003186_abnormal_redox_activity | 0.72216256 |
| 176 | MP0001873_stomach_inflammation | 0.72186323 |
| 177 | MP0003279_aneurysm | 0.68458568 |
| 178 | MP0010386_abnormal_urinary_bladder | 0.67531601 |
| 179 | MP0002136_abnormal_kidney_physiology | 0.66234190 |
| 180 | MP0001663_abnormal_digestive_system | 0.65785254 |
| 181 | MP0005319_abnormal_enzyme/_coenzyme | 0.64537976 |
| 182 | MP0003705_abnormal_hypodermis_morpholog | 0.62656342 |
| 183 | MP0002090_abnormal_vision | 0.60954284 |
| 184 | MP0000767_abnormal_smooth_muscle | 0.60178186 |
| 185 | MP0000490_abnormal_crypts_of | 0.56893602 |
| 186 | MP0005670_abnormal_white_adipose | 0.56460237 |
| 187 | MP0005334_abnormal_fat_pad | 0.54830673 |
| 188 | MP0000598_abnormal_liver_morphology | 0.53531395 |
| 189 | MP0009115_abnormal_fat_cell | 0.53118999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.40738501 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 7.08569950 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.46194259 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.33738053 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.27854351 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.92449851 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 5.65124821 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.25842477 |
| 9 | Glomerulonephritis (HP:0000099) | 5.20923462 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.81386997 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.72797571 |
| 12 | Pancreatic cysts (HP:0001737) | 4.44832972 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.27866300 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 4.27866300 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.27866300 |
| 16 | Abnormality of midbrain morphology (HP:0002418) | 4.27621425 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 4.27621425 |
| 18 | Chronic hepatic failure (HP:0100626) | 4.11843588 |
| 19 | Pancreatic fibrosis (HP:0100732) | 4.10764430 |
| 20 | Disinhibition (HP:0000734) | 4.06980332 |
| 21 | Abnormality of complement system (HP:0005339) | 4.02290123 |
| 22 | Complement deficiency (HP:0004431) | 3.95586916 |
| 23 | True hermaphroditism (HP:0010459) | 3.90886068 |
| 24 | Axonal loss (HP:0003447) | 3.89115731 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.86993900 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.86993900 |
| 27 | Congenital stationary night blindness (HP:0007642) | 3.85495088 |
| 28 | Gingivitis (HP:0000230) | 3.82174509 |
| 29 | Myocardial infarction (HP:0001658) | 3.80611106 |
| 30 | Recurrent skin infections (HP:0001581) | 3.79386594 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.76153750 |
| 32 | Obstructive lung disease (HP:0006536) | 3.70536262 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.70536262 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.66239184 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.66239184 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.66239184 |
| 37 | Myositis (HP:0100614) | 3.47783858 |
| 38 | Nephronophthisis (HP:0000090) | 3.43807930 |
| 39 | Orchitis (HP:0100796) | 3.23826602 |
| 40 | Type II lissencephaly (HP:0007260) | 3.19679229 |
| 41 | Prostate neoplasm (HP:0100787) | 3.14108807 |
| 42 | Nephritis (HP:0000123) | 3.12273222 |
| 43 | Recurrent fungal infections (HP:0002841) | 3.11555351 |
| 44 | Pustule (HP:0200039) | 3.10142558 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.08126499 |
| 46 | Abolished electroretinogram (ERG) (HP:0000550) | 3.03403451 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 3.02752916 |
| 48 | Hepatosplenomegaly (HP:0001433) | 3.01407987 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.97976378 |
| 50 | Optic neuritis (HP:0100653) | 2.97976378 |
| 51 | Abnormality of the renal cortex (HP:0011035) | 2.96193320 |
| 52 | Loss of speech (HP:0002371) | 2.95325696 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 2.92652834 |
| 54 | Joint hemorrhage (HP:0005261) | 2.91436664 |
| 55 | Thick nail (HP:0001805) | 2.82824087 |
| 56 | Agnosia (HP:0010524) | 2.82524372 |
| 57 | J-shaped sella turcica (HP:0002680) | 2.76892616 |
| 58 | Attenuation of retinal blood vessels (HP:0007843) | 2.73170249 |
| 59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.72911228 |
| 60 | Periodontitis (HP:0000704) | 2.72503630 |
| 61 | Cystic liver disease (HP:0006706) | 2.71601161 |
| 62 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71436420 |
| 63 | Pendular nystagmus (HP:0012043) | 2.68691239 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.68642869 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.67161539 |
| 66 | Increased CSF lactate (HP:0002490) | 2.67010800 |
| 67 | Urticaria (HP:0001025) | 2.66550102 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.65599962 |
| 69 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.64658431 |
| 70 | Progressive macrocephaly (HP:0004481) | 2.63566187 |
| 71 | Medial flaring of the eyebrow (HP:0010747) | 2.61673810 |
| 72 | Stomatitis (HP:0010280) | 2.61358971 |
| 73 | Upper motor neuron abnormality (HP:0002127) | 2.53138159 |
| 74 | 3-Methylglutaconic aciduria (HP:0003535) | 2.52847669 |
| 75 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.49176806 |
| 76 | Acute encephalopathy (HP:0006846) | 2.48791332 |
| 77 | Conjunctival telangiectasia (HP:0000524) | 2.47626171 |
| 78 | Cellulitis (HP:0100658) | 2.46699253 |
| 79 | Hematochezia (HP:0002573) | 2.41844166 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.41242265 |
| 81 | Hepatocellular necrosis (HP:0001404) | 2.40173193 |
| 82 | Abnormality of the labia minora (HP:0012880) | 2.40008016 |
| 83 | Abnormality of the lumbar spine (HP:0100712) | 2.39838189 |
| 84 | Retinal dysplasia (HP:0007973) | 2.37796345 |
| 85 | Intestinal atresia (HP:0011100) | 2.37507238 |
| 86 | Tubular atrophy (HP:0000092) | 2.36314086 |
| 87 | Keratoconus (HP:0000563) | 2.34097564 |
| 88 | Increased corneal curvature (HP:0100692) | 2.34097564 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 2.31856879 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31594852 |
| 91 | Pathologic fracture (HP:0002756) | 2.31240429 |
| 92 | Recurrent viral infections (HP:0004429) | 2.30877225 |
| 93 | Decreased central vision (HP:0007663) | 2.30370689 |
| 94 | Thoracic kyphosis (HP:0002942) | 2.29403665 |
| 95 | Sclerocornea (HP:0000647) | 2.29170366 |
| 96 | Osteomyelitis (HP:0002754) | 2.26224027 |
| 97 | Hyperventilation (HP:0002883) | 2.25034242 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 2.23938695 |
| 99 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23938695 |
| 100 | Meningitis (HP:0001287) | 2.22975519 |
| 101 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.22834090 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.22786473 |
| 103 | Hypercholesterolemia (HP:0003124) | 2.22758643 |
| 104 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21741668 |
| 105 | Polydipsia (HP:0001959) | 2.21647146 |
| 106 | Abnormal drinking behavior (HP:0030082) | 2.21647146 |
| 107 | Basal ganglia calcification (HP:0002135) | 2.20490275 |
| 108 | Hepatic necrosis (HP:0002605) | 2.19091107 |
| 109 | Nausea (HP:0002018) | 2.18785598 |
| 110 | Recurrent pneumonia (HP:0006532) | 2.18493802 |
| 111 | Optic disc pallor (HP:0000543) | 2.16653839 |
| 112 | Peripheral demyelination (HP:0011096) | 2.15586039 |
| 113 | Inability to walk (HP:0002540) | 2.15449128 |
| 114 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15288429 |
| 115 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15288429 |
| 116 | Pulmonary infiltrates (HP:0002113) | 2.14217590 |
| 117 | Petechiae (HP:0000967) | 2.14090450 |
| 118 | Xanthomatosis (HP:0000991) | 2.13359104 |
| 119 | Neoplasm of the adrenal cortex (HP:0100641) | 2.12239255 |
| 120 | Stomach cancer (HP:0012126) | 2.11448085 |
| 121 | Constricted visual fields (HP:0001133) | 2.11427731 |
| 122 | Abnormal biliary tract physiology (HP:0012439) | 2.09289255 |
| 123 | Bile duct proliferation (HP:0001408) | 2.09289255 |
| 124 | Anencephaly (HP:0002323) | 2.09227643 |
| 125 | Lissencephaly (HP:0001339) | 2.09052188 |
| 126 | Vasculitis (HP:0002633) | 2.08111764 |
| 127 | Prolonged bleeding time (HP:0003010) | 2.06274239 |
| 128 | Inappropriate behavior (HP:0000719) | 2.05962575 |
| 129 | Renal cortical cysts (HP:0000803) | 2.05531039 |
| 130 | Thyroid-stimulating hormone excess (HP:0002925) | 2.04453354 |
| 131 | Neurofibrillary tangles (HP:0002185) | 2.04257416 |
| 132 | Congenital hepatic fibrosis (HP:0002612) | 2.03813356 |
| 133 | Progressive visual loss (HP:0000529) | 2.03202085 |
| 134 | Bone pain (HP:0002653) | 2.03139295 |
| 135 | Arterial thrombosis (HP:0004420) | 2.03020892 |
| 136 | Colon cancer (HP:0003003) | 2.02633122 |
| 137 | Concave nail (HP:0001598) | 2.01806797 |
| 138 | Hypothermia (HP:0002045) | 2.01193662 |
| 139 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00749857 |
| 140 | Diminished motivation (HP:0000745) | 2.00193256 |
| 141 | Gingival bleeding (HP:0000225) | 1.99387020 |
| 142 | Thyroiditis (HP:0100646) | 1.98934054 |
| 143 | Furrowed tongue (HP:0000221) | 1.98375861 |
| 144 | Progressive inability to walk (HP:0002505) | 1.97546300 |
| 145 | Cerebellar dysplasia (HP:0007033) | 1.96199147 |
| 146 | Apathy (HP:0000741) | 1.96190078 |
| 147 | Leukocytosis (HP:0001974) | 1.95068022 |
| 148 | Gait imbalance (HP:0002141) | 1.94266759 |
| 149 | Absent speech (HP:0001344) | 1.94120462 |
| 150 | Colitis (HP:0002583) | 1.93779213 |
| 151 | Mutism (HP:0002300) | 1.93507927 |
| 152 | Male pseudohermaphroditism (HP:0000037) | 1.93166742 |
| 153 | Anorexia (HP:0002039) | 1.92481196 |
| 154 | Hypomagnesemia (HP:0002917) | 1.91241524 |
| 155 | Polyuria (HP:0000103) | 1.89723391 |
| 156 | Congenital primary aphakia (HP:0007707) | 1.89550351 |
| 157 | Focal motor seizures (HP:0011153) | 1.89484174 |
| 158 | Inflammation of the large intestine (HP:0002037) | 1.88992237 |
| 159 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.88341060 |
| 160 | Interstitial pulmonary disease (HP:0006530) | 1.87731551 |
| 161 | Hypokinesia (HP:0002375) | 1.86198771 |
| 162 | Global brain atrophy (HP:0002283) | 1.86086740 |
| 163 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.85102296 |
| 164 | Abnormality of the prostate (HP:0008775) | 1.84396500 |
| 165 | Keratoconjunctivitis sicca (HP:0001097) | 1.83137786 |
| 166 | Broad-based gait (HP:0002136) | 1.82311032 |
| 167 | Abnormality of macular pigmentation (HP:0008002) | 1.81817754 |
| 168 | Vertebral compression fractures (HP:0002953) | 1.81109952 |
| 169 | Cerebral edema (HP:0002181) | 1.80955137 |
| 170 | Hyperlipoproteinemia (HP:0010980) | 1.80739243 |
| 171 | Type I transferrin isoform profile (HP:0003642) | 1.80720317 |
| 172 | Hemiparesis (HP:0001269) | 1.79436300 |
| 173 | Febrile seizures (HP:0002373) | 1.79258444 |
| 174 | IgG deficiency (HP:0004315) | 1.79142710 |
| 175 | Neuronal loss in central nervous system (HP:0002529) | 1.79080816 |
| 176 | Severe visual impairment (HP:0001141) | 1.79009230 |
| 177 | Increased serum lactate (HP:0002151) | 1.77781843 |
| 178 | Optic nerve hypoplasia (HP:0000609) | 1.77752437 |
| 179 | Esophageal varix (HP:0002040) | 1.77495752 |
| 180 | Postaxial foot polydactyly (HP:0001830) | 1.77109816 |
| 181 | Mucosal telangiectasiae (HP:0100579) | 1.76840197 |
| 182 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.75458364 |
| 183 | Large for gestational age (HP:0001520) | 1.73821632 |
| 184 | Pachygyria (HP:0001302) | 1.72740533 |
| 185 | Abnormal protein glycosylation (HP:0012346) | 1.72262173 |
| 186 | Abnormal glycosylation (HP:0012345) | 1.72262173 |
| 187 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.72262173 |
| 188 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.72262173 |
| 189 | Abnormal albumin level (HP:0012116) | 1.70978427 |
| 190 | Hypoalbuminemia (HP:0003073) | 1.70978427 |
| 191 | Postaxial hand polydactyly (HP:0001162) | 1.70621919 |
| 192 | Agitation (HP:0000713) | 1.69578108 |
| 193 | Genital tract atresia (HP:0001827) | 1.68054931 |
| 194 | Severe muscular hypotonia (HP:0006829) | 1.67762823 |
| 195 | Hypoproteinemia (HP:0003075) | 1.67138305 |
| 196 | Albinism (HP:0001022) | 1.66900245 |
| 197 | Occipital encephalocele (HP:0002085) | 1.66249822 |
| 198 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.65277014 |
| 199 | Hypoplasia of the fovea (HP:0007750) | 1.65277014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.89836148 |
| 2 | BLK | 4.60911598 |
| 3 | RIPK4 | 3.93316306 |
| 4 | IRAK4 | 3.77493035 |
| 5 | MAP3K14 | 3.28718281 |
| 6 | TYK2 | 3.17209840 |
| 7 | GRK1 | 2.82872703 |
| 8 | TBK1 | 2.69725532 |
| 9 | KIT | 2.65134397 |
| 10 | TAOK3 | 2.61587002 |
| 11 | TGFBR2 | 2.39124402 |
| 12 | ZAK | 2.37440718 |
| 13 | MAP4K2 | 2.36951980 |
| 14 | IRAK3 | 2.36465251 |
| 15 | PBK | 2.28405850 |
| 16 | PINK1 | 2.21289019 |
| 17 | WNK3 | 2.20075061 |
| 18 | GRK7 | 2.14257957 |
| 19 | BCKDK | 2.10766318 |
| 20 | ACVR1B | 2.06507254 |
| 21 | ERN1 | 2.02285207 |
| 22 | MAP4K1 | 2.01435050 |
| 23 | EIF2AK3 | 2.01360390 |
| 24 | FGR | 1.97445722 |
| 25 | CSF1R | 1.83711208 |
| 26 | MAPK13 | 1.82031381 |
| 27 | FES | 1.81958369 |
| 28 | TRIM28 | 1.78930449 |
| 29 | IKBKB | 1.78437033 |
| 30 | CSK | 1.73662005 |
| 31 | JAK1 | 1.69354117 |
| 32 | INSRR | 1.66145452 |
| 33 | NEK9 | 1.61394302 |
| 34 | IKBKE | 1.60884318 |
| 35 | HCK | 1.53019137 |
| 36 | TIE1 | 1.52370380 |
| 37 | VRK2 | 1.50297693 |
| 38 | EPHB1 | 1.50178538 |
| 39 | BTK | 1.48879206 |
| 40 | STK10 | 1.45458096 |
| 41 | CAMK1D | 1.44802019 |
| 42 | PIM2 | 1.44639241 |
| 43 | MST4 | 1.44581118 |
| 44 | OXSR1 | 1.38601870 |
| 45 | ZAP70 | 1.37456964 |
| 46 | TXK | 1.36416899 |
| 47 | RIPK1 | 1.35908346 |
| 48 | LYN | 1.35051230 |
| 49 | SYK | 1.34815910 |
| 50 | STK38L | 1.33814111 |
| 51 | WNK4 | 1.33462052 |
| 52 | CASK | 1.29923501 |
| 53 | NME2 | 1.28421906 |
| 54 | TNIK | 1.23198340 |
| 55 | TEC | 1.23141616 |
| 56 | MKNK2 | 1.22909309 |
| 57 | TAF1 | 1.22626478 |
| 58 | DYRK2 | 1.21778768 |
| 59 | TLK1 | 1.21730577 |
| 60 | JAK2 | 1.16971143 |
| 61 | LCK | 1.16246755 |
| 62 | CLK1 | 1.14821681 |
| 63 | MAP2K3 | 1.09665011 |
| 64 | PLK2 | 1.08113318 |
| 65 | ABL2 | 1.06281217 |
| 66 | SIK2 | 1.06055085 |
| 67 | MAP3K4 | 1.05988470 |
| 68 | BMX | 1.05853670 |
| 69 | JAK3 | 1.05774816 |
| 70 | STK39 | 1.04796402 |
| 71 | PAK3 | 1.00642076 |
| 72 | NLK | 0.96173434 |
| 73 | MAP3K13 | 0.95638690 |
| 74 | ADRBK1 | 0.95514327 |
| 75 | PRKCE | 0.93096840 |
| 76 | EGFR | 0.92877152 |
| 77 | BMPR2 | 0.90677554 |
| 78 | TTN | 0.90018942 |
| 79 | MATK | 0.89557554 |
| 80 | MARK1 | 0.88825122 |
| 81 | TGFBR1 | 0.88100808 |
| 82 | STK16 | 0.87964345 |
| 83 | TRIB3 | 0.87771612 |
| 84 | CHUK | 0.86730194 |
| 85 | BCR | 0.86599004 |
| 86 | CAMK1G | 0.85350724 |
| 87 | VRK1 | 0.84886172 |
| 88 | CDK6 | 0.83430085 |
| 89 | MARK3 | 0.81478964 |
| 90 | MOS | 0.81322365 |
| 91 | YES1 | 0.80496856 |
| 92 | NTRK3 | 0.80052619 |
| 93 | CSNK1G1 | 0.79995425 |
| 94 | PLK4 | 0.79364942 |
| 95 | PNCK | 0.79342965 |
| 96 | TRPM7 | 0.79230809 |
| 97 | PRKCD | 0.77341657 |
| 98 | PIM1 | 0.77251070 |
| 99 | ABL1 | 0.76186485 |
| 100 | MAP3K3 | 0.73328715 |
| 101 | MKNK1 | 0.72602116 |
| 102 | ITK | 0.72588351 |
| 103 | CAMKK2 | 0.71285660 |
| 104 | PLK3 | 0.70594088 |
| 105 | GRK6 | 0.70286592 |
| 106 | ADRBK2 | 0.70023401 |
| 107 | PHKG2 | 0.69178260 |
| 108 | PHKG1 | 0.69178260 |
| 109 | CSNK1G3 | 0.68541411 |
| 110 | EIF2AK2 | 0.68430852 |
| 111 | MST1R | 0.66741271 |
| 112 | CSNK1G2 | 0.65719997 |
| 113 | PKN2 | 0.65694535 |
| 114 | MAPKAPK3 | 0.64836339 |
| 115 | MAP2K7 | 0.63702436 |
| 116 | STK4 | 0.63424936 |
| 117 | CSNK1A1L | 0.62155607 |
| 118 | LATS1 | 0.61724536 |
| 119 | MAP3K11 | 0.61169972 |
| 120 | CAMKK1 | 0.61035155 |
| 121 | PTK6 | 0.60427335 |
| 122 | PRKCG | 0.59759799 |
| 123 | STK3 | 0.57666743 |
| 124 | PAK4 | 0.56115300 |
| 125 | EIF2AK1 | 0.55855701 |
| 126 | FYN | 0.55123588 |
| 127 | PRKCI | 0.53178966 |
| 128 | SCYL2 | 0.52182824 |
| 129 | GRK5 | 0.51697643 |
| 130 | LRRK2 | 0.51237055 |
| 131 | MAP2K6 | 0.51141457 |
| 132 | STK11 | 0.50379116 |
| 133 | MAP2K2 | 0.48219767 |
| 134 | MAPKAPK2 | 0.45820344 |
| 135 | IGF1R | 0.45718540 |
| 136 | PIK3CG | 0.44989270 |
| 137 | PRKACA | 0.44877817 |
| 138 | TESK2 | 0.44411385 |
| 139 | DYRK1A | 0.44343826 |
| 140 | DAPK2 | 0.43085283 |
| 141 | BRSK2 | 0.42645266 |
| 142 | CAMK2A | 0.42471958 |
| 143 | ERBB3 | 0.42295086 |
| 144 | RPS6KA5 | 0.42023127 |
| 145 | FGFR2 | 0.41820973 |
| 146 | SIK3 | 0.41755151 |
| 147 | CSNK1A1 | 0.41406089 |
| 148 | FGFR3 | 0.40996708 |
| 149 | IRAK1 | 0.40930837 |
| 150 | PRKCZ | 0.40768183 |
| 151 | RPS6KA6 | 0.40587558 |
| 152 | STK38 | 0.40077178 |
| 153 | RPS6KA4 | 0.39618603 |
| 154 | CDC7 | 0.39585110 |
| 155 | PRKCH | 0.39537085 |
| 156 | PDGFRB | 0.39101682 |
| 157 | PRKCQ | 0.38870275 |
| 158 | RPS6KL1 | 0.37822303 |
| 159 | RPS6KC1 | 0.37822303 |
| 160 | MAPKAPK5 | 0.36903781 |
| 161 | NME1 | 0.36840756 |
| 162 | PLK1 | 0.35870006 |
| 163 | ATR | 0.35476668 |
| 164 | NTRK2 | 0.35313674 |
| 165 | EPHA4 | 0.34996112 |
| 166 | DYRK1B | 0.34218868 |
| 167 | STK24 | 0.33764231 |
| 168 | MAPK4 | 0.33716366 |
| 169 | CDK9 | 0.33296377 |
| 170 | GSK3A | 0.32477217 |
| 171 | BMPR1B | 0.31403553 |
| 172 | PDK1 | 0.31132344 |
| 173 | TNK2 | 0.30769811 |
| 174 | PKN1 | 0.29727221 |
| 175 | PTK2B | 0.27709083 |
| 176 | MET | 0.27343429 |
| 177 | NUAK1 | 0.27143167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.44647031 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.58338892 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.52578598 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.27819446 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 3.06735215 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.87175879 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.62595862 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.61924090 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.59570926 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58104063 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.49341464 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.47770443 |
| 13 | Phagosome_Homo sapiens_hsa04145 | 2.47171098 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.46747815 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.46490385 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41321606 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.37085181 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.34761628 |
| 19 | Protein export_Homo sapiens_hsa03060 | 2.26655111 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.23826698 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.20929471 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 2.16725172 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12782130 |
| 24 | Malaria_Homo sapiens_hsa05144 | 2.09084502 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 2.06167057 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00501669 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.96020088 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94699881 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92605492 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.87177930 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.81709890 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.79616542 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.76551588 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.74447378 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.73830775 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.71143975 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68899959 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64103828 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.57727399 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48904252 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.48112139 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47280932 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44909883 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43575100 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.41408401 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41384491 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39916406 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.38719538 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.38522705 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.36837627 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36386189 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34645473 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33568758 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32927221 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28533198 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27363318 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25788131 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 1.25105514 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24170122 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23588045 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 1.20927744 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19781245 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17878498 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 1.16976899 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16247627 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.15917098 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 1.13592516 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13293313 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 1.11907412 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10256360 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10045085 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09473802 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 1.08926702 |
| 74 | Asthma_Homo sapiens_hsa05310 | 1.07390391 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06346737 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06142549 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03669134 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.02274830 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99831753 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.99205542 |
| 81 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.98936999 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98651136 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94065613 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.93759409 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91884047 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91158648 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90229659 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.88606820 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88381359 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88304630 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88079684 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88066453 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87437309 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86603327 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84896981 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84665902 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82507069 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79614839 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79085356 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.79029804 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.78511809 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.74016026 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72868945 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69482271 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68014860 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67760513 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67533868 |
| 108 | Base excision repair_Homo sapiens_hsa03410 | 0.65422688 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.65392927 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64051643 |
| 111 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64013614 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63397152 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63054654 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62216274 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.61589134 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60793767 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.59989056 |
| 118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59610661 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58234939 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57881588 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57660141 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55397999 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55115076 |
| 124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54668008 |
| 125 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54357081 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.54263055 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53122044 |
| 128 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52889562 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52614382 |
| 130 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51378852 |
| 131 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50724405 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50094073 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48609071 |
| 134 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48543730 |
| 135 | Salivary secretion_Homo sapiens_hsa04970 | 0.48080843 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.47872824 |
| 137 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47486442 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45099819 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44160265 |
| 140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44139082 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43959654 |
| 142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43297603 |
| 143 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43133275 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39471880 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39202944 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.39010651 |
| 147 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38570613 |
| 148 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38184361 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36770370 |
| 150 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36555160 |
| 151 | Ribosome_Homo sapiens_hsa03010 | 0.36157924 |
| 152 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35731369 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34236647 |
| 154 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33060826 |
| 155 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33036085 |
| 156 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.31996664 |
| 157 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31462655 |
| 158 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31095391 |
| 159 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28136091 |
| 160 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27273009 |
| 161 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26519327 |
| 162 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24693032 |
| 163 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23873566 |
| 164 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21399327 |
| 165 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21285872 |
| 166 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21004438 |
| 167 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20459264 |
| 168 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19299133 |
| 169 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19137109 |
| 170 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.18982099 |
| 171 | Insulin resistance_Homo sapiens_hsa04931 | 0.17394323 |
| 172 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17236005 |

